Invest New Drugs

2018/06/01

Ozaki A, Takita M, Tanimoto T. A call for improved transparency in financial aspects of clinical trials: a case study of the CREATE-X trial in the New England Journal of Medicine. Invest New Drugs. 36:517-522, 2018.(Jun)

https://www.ncbi.nlm.nih.gov/pubmed/29516231

Share on Facebook
Share on Twitter
Please reload